Viewing Study NCT00519467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2025-12-25 @ 11:09 PM
Study NCT ID: NCT00519467
Status: COMPLETED
Last Update Posted: 2016-12-06
First Post: 2007-08-20
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dose-ranging study View
None SB-714703 View
None artesunate, View
None malaria View
None CDA, View
None chlorproguanil, View
None dapsone, View